Patterson Companies - PDCO Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $34.00
  • Forecasted Upside: 28.93%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
▼ -0.01 (-0.04%)

This chart shows the closing price for PDCO by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Patterson Companies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PDCO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PDCO

Analyst Price Target is $34.00
▲ +28.93% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Patterson Companies in the last 3 months. The average price target is $34.00, with a high forecast of $40.00 and a low forecast of $30.00. The average price target represents a 28.93% upside from the last price of $26.37.

This chart shows the closing price for PDCO for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 4 investment analysts is to hold stock in Patterson Companies. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/30/2023Piper SandlerLower TargetOverweight ➝ Overweight$39.00 ➝ $34.00Low
11/30/2023Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$38.00 ➝ $35.00Low
11/30/2023The Goldman Sachs GroupLower TargetNeutral ➝ Neutral$35.00 ➝ $30.00Low
11/28/2023Stifel NicolausReiterated RatingHold ➝ Hold$32.00Low
10/11/2023Evercore ISILower Target$36.00 ➝ $32.00Low
8/31/2023Stifel NicolausReiterated RatingHold ➝ Hold$32.00Low
6/22/2023Piper SandlerBoost Target$35.00 ➝ $39.00Low
6/22/2023Stifel NicolausBoost Target$30.00 ➝ $32.00Low
6/22/2023Robert W. BairdBoost Target$31.00 ➝ $35.00Low
6/22/2023Bank of AmericaBoost Target$35.00 ➝ $40.00Low
2/6/2023Piper SandlerBoost TargetOverweight$35.00 ➝ $37.00Low
12/2/2022Evercore ISIBoost Target$30.00Low
11/28/2022Credit Suisse GroupBoost TargetOutperform$39.00Low
10/17/2022Piper SandlerLower TargetOverweight$40.00 ➝ $35.00Low
9/6/2022Evercore ISILower Target$26.50Low
9/6/2022Robert W. BairdLower Target$33.00Low
9/6/2022The Goldman Sachs GroupLower TargetNeutral$34.00 ➝ $30.00Low
9/2/2022William BlairReiterated RatingMarket PerformLow
9/1/2022Piper SandlerLower TargetOverweight$42.00 ➝ $40.00Low
6/30/2022Credit Suisse GroupBoost TargetOutperform$36.00 ➝ $37.00Low
6/29/2022Piper SandlerBoost TargetOverweight$41.00 ➝ $42.00Low
6/20/2022Robert W. BairdSet Target$35.00Low
4/14/2022Morgan StanleyBoost TargetEqual Weight$32.00 ➝ $36.00Low
3/3/2022Morgan StanleyBoost TargetEqual Weight$30.00 ➝ $32.00Medium
1/31/2022Morgan StanleyInitiated CoverageEqual Weight$30.00High
6/24/2021Robert W. BairdLower TargetNeutral$37.00 ➝ $35.00Low
6/23/2021Piper SandlerLower TargetOverweight$44.00 ➝ $41.00Low
6/17/2021Piper SandlerUpgradeNeutral ➝ Overweight$34.00 ➝ $44.00High
12/3/2020BarclaysBoost TargetUnderweight$21.00 ➝ $25.00Medium
12/2/2020Piper SandlerBoost TargetNeutral$25.00 ➝ $33.00High
11/10/2020GuggenheimDowngradeBuy ➝ NeutralLow
9/4/2020BarclaysBoost TargetUnderweight$18.00 ➝ $21.00Medium
8/27/2020Bank of AmericaBoost TargetBuy$27.50 ➝ $31.00Low
7/20/2020Bank of AmericaBoost TargetBuy$23.00 ➝ $27.50High
6/29/2020Credit Suisse GroupReiterated RatingBuyLow
6/26/2020UBS GroupBoost TargetNeutral$20.00 ➝ $21.00High
6/25/2020JPMorgan Chase & Co.Boost TargetNeutral$19.00 ➝ $21.00High
6/25/2020The Goldman Sachs GroupUpgradeSell ➝ Neutral$11.00 ➝ $21.00High
4/2/2020Wolfe ResearchUpgradeUnderperform ➝ Market PerformMedium
3/20/2020BarclaysReiterated RatingSell$16.00Medium
2/28/2020Robert W. BairdBoost TargetNeutral$22.00 ➝ $28.00Low
2/28/2020JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$20.00 ➝ $25.00High
2/28/2020BarclaysReiterated RatingSell$21.00High
2/27/2020Bank of AmericaUpgradeNeutral ➝ Buy$28.00High
1/9/2020Bank of AmericaUpgradeUnderperform ➝ Neutral$19.50 ➝ $22.50Medium
1/7/2020GuggenheimUpgradeNeutral ➝ Buy$25.00High
12/18/2019CfraUpgradeStrong Sell ➝ HoldLow
12/6/2019JPMorgan Chase & Co.Boost TargetUnderweight$18.00 ➝ $20.00Medium
12/6/2019Robert W. BairdBoost TargetNeutral$19.00 ➝ $22.00Low
12/4/2019William BlairReiterated RatingMarket PerformHigh
9/6/2019UBS GroupLower TargetNeutral$23.00 ➝ $16.00Low
8/30/2019The Goldman Sachs GroupSet TargetSell$15.00Low
8/30/2019Robert W. BairdSet TargetHold$19.00Low
8/30/2019Wolfe ResearchSet TargetSell$17.00Low
8/30/2019BarclaysLower TargetUnderweight$20.00 ➝ $16.00Low
6/28/2019JPMorgan Chase & Co.Lower TargetUnderweight$22.00 ➝ $20.00High
6/25/2019UBS GroupSet TargetHold$24.00High
5/30/2019Wolfe ResearchInitiated CoverageUnderperform ➝ UnderperformLow
4/17/2019GuggenheimInitiated CoverageNeutral ➝ Neutral$23.00Medium
1/17/2019UBS GroupInitiated CoverageNeutral ➝ Neutral$23.00Low
(Data available from 12/7/2018 forward)

News Sentiment Rating

0.08 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 9 very positive mentions
  • 40 positive mentions
  • 10 negative mentions
  • 5 very negative mentions
  • 20 very positive mentions
  • 33 positive mentions
  • 13 negative mentions
  • 15 very negative mentions
  • 21 very positive mentions
  • 33 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
  • 15 very positive mentions
  • 35 positive mentions
  • 1 negative mentions
  • 2 very negative mentions
  • 21 very positive mentions
  • 46 positive mentions
  • 6 negative mentions
  • 5 very negative mentions
  • 12 very positive mentions
  • 27 positive mentions
  • 18 negative mentions
  • 7 very negative mentions
  • 9 very positive mentions
  • 24 positive mentions
  • 12 negative mentions
  • 9 very negative mentions
  • 7 very positive mentions
  • 38 positive mentions
  • 4 negative mentions
  • 5 very negative mentions

Current Sentiment

  • 7 very positive mentions
  • 38 positive mentions
  • 4 negative mentions
  • 5 very negative mentions

Recent Stories by Sentiment

Patterson Companies logo
Patterson Companies, Inc. engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems. It also provides a range of related services comprising software and design services, maintenance and repair, and equipment financing. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional's, consumable supplies, equipment, and software, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota.
Read More

Today's Range

Now: $26.37
Low: $26.29
High: $26.88

50 Day Range

MA: $30.05
Low: $25.41
High: $32.55

52 Week Range

Now: $26.37
Low: $25.00
High: $34.53


843,050 shs

Average Volume

844,724 shs

Market Capitalization

$2.44 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Patterson Companies?

The following Wall Street sell-side analysts have issued stock ratings on Patterson Companies in the last twelve months: Bank of America Co., Evercore ISI, Morgan Stanley, Piper Sandler, Robert W. Baird, Stifel Nicolaus,, and The Goldman Sachs Group, Inc..
View the latest analyst ratings for PDCO.

What is the current price target for Patterson Companies?

7 Wall Street analysts have set twelve-month price targets for Patterson Companies in the last year. Their average twelve-month price target is $34.00, suggesting a possible upside of 28.9%. Bank of America Co. has the highest price target set, predicting PDCO will reach $40.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of $30.00 for Patterson Companies in the next year.
View the latest price targets for PDCO.

What is the current consensus analyst rating for Patterson Companies?

Patterson Companies currently has 3 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in PDCO, but not buy more shares or sell existing shares.
View the latest ratings for PDCO.

What other companies compete with Patterson Companies?

Other companies that are similar to Patterson Companies include Owens & Minor, Privia Health Group, Premier, ImmunityBio and GoodRx. Learn More about companies similar to Patterson Companies.

How do I contact Patterson Companies' investor relations team?

Patterson Companies' physical mailing address is 1031 MENDOTA HEIGHTS RD, ST PAUL MN, 55120. The company's listed phone number is (651) 686-1600 and its investor relations email address is [email protected]. The official website for Patterson Companies is Learn More about contacing Patterson Companies investor relations.